Ghielmini, Michele

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 9.

Journal Article

Ghilardi, Guido; Pabst Müller, Thomas Niklaus; Jeker, Barbara; Müller, Rouven; Cairoli, Anne; Müller, Antonia M S; Bargetzi, Mario; Hitz, Felicitas; Baldomero, Helen; Heim, Dominik; Schmidt, Adrian; Rossi, Davide; Ghielmini, Michele; Wannesson, Luciano; Lerch, Erika; Samaras, Panagiotis; Schanz, Urs; Passweg, Jakob R; Stussi, Georg; Kleber, Martina; ... (2019). Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study. Bone marrow transplantation, 54(7), pp. 1029-1037. Nature Publishing Group 10.1038/s41409-018-0379-y

Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J. M.; Rauch, Daniel; Wahlin, Björn E.; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J. M.; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; ... (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), pp. 353-362. American Society of Hematology 10.1182/blood-2018-10-879643

Voegeli, Michèle; Rondeau, Stephanie; Berardi Vilei, Simona; Lerch, Erika; Wannesson, Luciano; Pabst, Thomas; Rentschler, Jochen; Bargetzi, Mario; Jost, Lorenz; Ketterer, Nicolas; Bischof Delaloye, Angelika; Ghielmini, Michele (2017). Y(90) -Ibritumomab tiuxetan (Y(90) -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05). Hematological oncology, 35(4), pp. 576-583. Wiley 10.1002/hon.2348

Taverna, Christian; Martinelli, Giovanni; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Vanazzi, Anna; Laszlo, Daniele; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Biaggi Rudolf, Christine; Rondeau, Stéphanie; Rusterholz, Corinne; Heijnen, Ingmar A F M; Zucca, Emanuele; Ghielmini, Michele (2016). Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. Journal of clinical oncology, 34(5), pp. 495-500. American Society of Clinical Oncology 10.1200/JCO.2015.61.3968

Vidal, Liat; Gafter-Gvili, Anat; Salles, Gilles; Dreyling, Martin H.; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Pettengell, Ruth; Witzens-Harig, Mathias; Shpilberg, Ofer (2011). Rituximab maintenance for the treatment of patients with follicular lymphoma: An updated systematic review and meta-analysis of randomized trials. Journal of the National Cancer Institute JNCI, 103(23), pp. 1799-1806. Cary, N.C.: Oxford University Press 10.1093/jnci/djr418

Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Utiger, Urs; Cerny, Thomas; Hess, Urs; Bassi, Simona; Okkinga, Emmie; Stupp, Roger; Stahel, Rolf; Heizmann, Marc; Vorobiof, Daniel; Lohri, Andreas; Dietrich, Pierre-Yves; Zucca, Emanuele; Ghielmini, Michele (2010). Long Term Follow-Up Of Patients With Follicular Lymphoma Receiving Single Agent Rituximab At Two Different Schedules In Trial SAKK 35/98. Journal of clinical oncology, 28(29), pp. 4480-4484. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.28.4786

Vidal, Liat; Gafter-Gvili, Anat; Leibovici, Leonard; Dreyling, Martin; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Cohen, Amos; Shpilberg, Ofer (2009). Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. Journal of the National Cancer Institute JNCI, 101(4), pp. 248-255. Cary, N.C.: Oxford University Press 10.1093/jnci/djn478

Conference or Workshop Item

Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Martinelli, Giovanni; Peccatori, F; Hess, Urs; Fey, Martin; Zucca, Emanuele; Stahel, Rolf; Ketterer, Nicolas; Cerny, Thomas (2009). Long-term follow-up of patients with follicular lymphoma (FL) receiving single agent rituximab at two different schedules in study SAKK 35/98. Journal of clinical oncology, 27(15), p. 8512. American Society of Clinical Oncology

Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Hess, Urs; Okkinga, Emmie; Stupp, Roger; Taverna, Christian; Vorobiof, Daniel; Heizman, Marc; Dietrich, Pierre-Yves; Ghielmini, Michele (2009). Long-term follow-up of follicular lymphoma (FL) patients receiving single agent rituximab at two different schedules in trial SAKK 35/98. European journal of cancer, 7(2), p. 562. Elsevier 10.1016/S1359-6349(09)71897-X

This list was generated on Sat Jun 6 09:28:16 2020 CEST.
Provide Feedback